SFRP4 and dentin dysplasia: We then used recombinant human WNT3A, SFRP4, or a combination of the two proteins to stimulate DD-tissue-derived myofibroblasts, palmar-skin-derived fibroblasts, and non-palmar-skin-derived fibroblasts from four unrelated DD-affected individuals.